Notwithstanding, E.G7 lymphoma cells were shown for the first time to reduce dendritic cell activation of peptide-specific CD4+ T cells through a soluble factor rather than a cell contact-dependent mechanism. This evidence concerns the gene CD4 and lymphoma.